Radcliffe Capital Management’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-54,666	Closed	-$5.52M	–	1222
2021 Q4	$5.52M	Buy	54,666 +19,788	+57%	+$2M	0.14%	132
2021 Q3	$3.52M	Sell	34,878 -122	-0.3%	-$12.3K	0.1%	287
2021 Q2	$3.49M	Hold	35,000	–	–	0.11%	305
2021 Q1	$3.44M	Buy	+35,000	New	+$3.44M	0.14%	290